Log In
BCIQ
Print this Print this
 

Adenoviral IL24 (Ad-IL24)

  Manage Alerts
Collapse Summary General Information
Company MultiVir Inc.
DescriptionAdenovirus modified to deliver the tumor suppressor gene interleukin-24 (IL-24; MDA7)
Molecular Target Interleukin-24 (IL-24) (MDA7)
Mechanism of Action 
Therapeutic ModalityGene therapy: Viral vector: Adenovirus
Latest Stage of DevelopmentPhase I
Standard IndicationMelanoma
Indication DetailsTreat melanoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today